The dual inhibitor of GLS and GDH, CPD‐3B (Hexylselen) has demonstrated to effectively disrupt mitochondrial membrane potential and to induce apoptosis of glutamine addicted cancer cells without showing toxicity to normal cells [113]. This evidence concerns the gene GLS and cancer.